Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Navidea Biopharmaceuticals Inc

(AMEX: NAVB)
Add to Portfolio
unch (unch)
as of Sep 20, 2019

Last 0.90
Change unch (unch)
Open 0.93
Prev. Close 0.90
Today's Range
0.88
0.96
52wk Range
0.49
7.40
Volume 300,400
Avg Volume 110,265
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
NAVB unch +33.48% -81.98%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS -1.28
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 8,040
Weighted Alpha -63.79
Standard Deviation -0.15
Profit Margin N/A
Beta 0.57

Growth Rates

YTD -54.95%
1-Year -82.67%
3-Year -95.16%
5-Year -96.45%
10-Year -96.77%

Opinion

Sell Hold Buy

Recent Headlines

Navidea Biopharmaceuticals to Present at the H.C.

BusinessWire via COMTEX - Fri Sep 06, 04:05PM EDT
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that its Chief Executive Office(full story)
NAVB: 0.90 (unch)

Navidea Biopharmaceuticals Announces Receipt of Notice

BusinessWire via COMTEX - Tue Aug 27, 07:30AM EDT
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced receipt of the Notice of Award (full story)
NAVB: 0.90 (unch)

LaVoieHealthScience Looks to the Future, Promotes

BusinessWire via COMTEX - Tue Aug 13, 02:51PM EDT
LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the promotion of two of the agency's senior-level employees. Sharon Corr(full story)
NAVB: 0.90 (unch)

Navidea Biopharmaceuticals Reports Second Quarter 2019

BusinessWire via COMTEX - Thu Aug 08, 04:05PM EDT
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the s(full story)
NAVB: 0.90 (unch)

Navidea Biopharmaceuticals Schedules Second Quarter

BusinessWire via COMTEX - Thu Aug 01, 04:05PM EDT
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call (full story)
NAVB: 0.90 (unch)